Note: Where available, the PDF/Word icon below is provided to view the complete and fully formatted document


Mrs Moylan, pursuant to notice, moved—That this House:

(1) notes:

 (a) the alarming rise in the number of people with Type 2 Diabetes estimated to be 1 million, with half of those people currently undiagnosed;

(b) according to a recent landmark study by Diab Cost Australia Type 2 Diabetes is costing Australians a staggering $3 billion a year with the bill for each person averaging nearly $11,000 in expenditure and benefits;

(c) according to the study, as the complications of diabetes increase, the costs per person are estimated to escalate from $4,020 to $9,625 when there are both microvascular and macrovascular problems;

(d) early detection through screening programs and action to slow or prevent the onset of complications will see reductions in health costs and improve and maintain quality of life for individuals with Type 2 Diabetes; and

(e) the contribution this landmark study conducted by Associate Professor Stephen Colaguiuri of Diab Cost Australia will make to better informing Government and the public of a significant public health problem;

(2) congratulates the Federal Government for the emphasis it has placed on public awareness programs in relation to Type 2 Diabetes; and

(3) urges the Government to:

 (a) continue programs to raise public awareness of the high risk of undiagnosed and untreated cases of Type 2 Diabetes and ensure access to appropriate screening;

(b) support access to new medications for the treatment of Type 2 Diabetes while ensuring that Australian taxpayers get value for money through appropriate pricing arrangements;

(c) continue to encourage people diagnosed with Diabetes to undergo regular medical testing including eye testing so as to prevent complications;

(d) ensure adequate funding for further research into prevention and treatment of Type 2 Diabetes; and

(e) develop a strong education program encouraging appropriate diet and exercise regimes to minimise the risk of Type 2 Diabetes.

Debate ensued.

The time allotted for the debate having expired, the debate was interrupted, and the resumption of the debate made an order of the day for the next sitting.